Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/14/22 → 4/6/23 |
Funding
- PPD Investigator Services LLC: $50,868.00
TAK-071-2002: A Randomized, Double-Blind, Placebo-Controlled, 2 Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients with Cognitive Impairment
- Slevin, John (PI)